Difference between revisions of "Fludarabine (Fludara)"
m (Text replace - "package insert<ref name="insert"></ref>." to "prescribing information.<ref name="insert"></ref>") |
|||
| Line 9: | Line 9: | ||
*[http://chemocare.com/bio/fludarabine.asp Fludarabine (Fludara) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/fludarabine.asp Fludarabine (Fludara) patient drug information (Chemocare)]</ref> | *[http://chemocare.com/bio/fludarabine.asp Fludarabine (Fludara) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/fludarabine.asp Fludarabine (Fludara) patient drug information (Chemocare)]</ref> | ||
*[http://www.uptodate.com/contents/fludarabine-patient-drug-information Fludarabine (Fludara) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/fludarabine-patient-drug-information Fludarabine (Fludara) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/fludarabine-patient-drug-information Fludarabine (Fludara) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/fludarabine-patient-drug-information Fludarabine (Fludara) patient drug information (UpToDate)]</ref> | ||
| + | |||
| + | ==History of changes in FDA indication== | ||
| + | * 4/18/1991: Initial FDA approval | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 15:31, 6 June 2013
General information
Class/mechanism: Purine analog, antimetabolite; fludarabine is converted to the active compound, 2-fluoro-ara-ATP, which inhibits DNA synthesis by inhibiting DNA polymerase alpha, ribonucleotide reductase, and DNA primase. Relatively resistant to deamination by adenosine deaminase. The mechanism of action is not completely characterized and may be multi-faceted.[1][2]
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
- Fludarabine (Fludara) patient drug information (Chemocare)[3]
- Fludarabine (Fludara) patient drug information (UpToDate)[4]
History of changes in FDA indication
- 4/18/1991: Initial FDA approval